Awards and Recognitions Dr. Sherry Yun Wang served as an invited grant reviewer for the U.S. Department of Veterans Affairs (VA) Health Systems Research (HSR) Scientific Merit Review Board (SMRB). Grants Dr. Jeff Goad was awarded a grant ($106,094) from the Merck Foundation as primary investigator on the study “A Prospective Survey Study Using Discrete
Grants Dr. Keykavous Parang (Conference Chair) and Dr. Enrique Seoane-Vazquez (Conference Chair): The Fight Against Infectious Diseases: Addressing the Challenges of Antibiotic-Resistant Bacteria, 2026-2027 On-Campus Conference Award, $8,000. Publications Dr. LB Brown and others published “Consumer data insights on pharmacy utilization: Comparative study of 2015 and 2021 surveys.” in the Journal of the American Pharmacy
After nearly 35 years of service in academia, Mary Gutierrez will retire in December 2025, concluding a career marked by expertise and a commitment to advancing pharmacy. A nationally recognized authority in psychiatric pharmacy, Gutierrez has long been board-certified by the Board of Pharmaceutical Specialties and has contributed to the evolving practices of mental health
The National Cancer Institute (NCI) has awarded a $415,500 Academic Research Enhancement Award (R15) to Keykavous Parang, Pharm.D., Ph.D., and Sun “Coco” Yang, Ph.D., to support their innovative cancer research at Chapman University. The project develops next-generation peptide-drug conjugates (PDCs) designed to improve the safety and effectiveness of doxorubicin (DOX), a chemotherapy drug commonly used
Sun “Coco” Yang, Ph.D., has been awarded a $3 million 5-year R01 from the National Institutes of Health as Principal Investigator to advance care for melanoma, an aggressive form of skin cancer. Yang, Associate Professor in the Department of Pharmacy Practice, is a clinical scientist with dual expertise in clinical pharmacy and basic research. In
The Center for Targeted Drug Delivery (CTDD) is our latest research center, created to advance precision drug delivery technologies and translate novel technologies into impactful therapies. The CTDD provides a formal structure that will deepen interdisciplinary collaborations among faculty researchers, industry partners, and other leading research institutions, while also attracting new partnerships. By uniting researchers
Enrique Seoane-Vazquez, Ph.D., has been awarded a two-year, multi–Principal Investigator grant for his project, “Advanced Therapy Medicinal Products: Clinical and Patient-Centered Outcomes.” The project will conduct the most comprehensive evaluation to date of Advanced Therapy Medicinal Products (ATMPs) between 2010 and 2025, and is funded by Arnold Ventures. The study will assess: Safety, efficacy, and
Awards and Recognitions Dr. Albert Bach has been appointed to the CalRx Insulin Patient Advisory Council, which serves as a crucial link between the CalRx Program and the diabetes patient community. It provides input and guidance to advance awareness, education, and advocacy for CalRx’s low-cost, biosimilar insulin products. The only health providers on the council
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded Cintia Citterio, Ph.D., a $1.7 million, five-year R01 grant as the sole Principal Investigator. Citterio joined CUSP in August of 2023 as an Assistant Professor funded by a K01 award from the NIDDK. This major award builds on the success of that
In August 2025, Kathleen “Kathy” Besinque, Pharm.D., retired from teaching following a distinguished 42-year career in pharmacy education. Besinque’s retirement was appropriately marked by being awarded the 2025 Pharmacist of the Year by California Society of Health-System Pharmacists (CSHP). Besinque’s career is defined by her service and advocacy to the pharmacy profession, and she is